Clinical trial
Exploratory Clinical Study to Evaluate Sodium Oxybate (Xyrem) on Potential…
NCT00345800 · UCB Pharma SA, Industry · Completed
Key facts
| NCT number | NCT00345800 |
|---|---|
| Title | Exploratory Clinical Study to Evaluate Sodium Oxybate (Xyrem) on Potential Endocrine Changes |
| Official title | Single Center, Therapeutic Exploratory Clinical Trial to Evaluate the Safety of Sodium Oxybate (Xyrem) 500 mg/mL Oral Solution on Potential Endocrine Changes at Currently Labeled Therapeutic Dose Regimens (4.5 - 9 g/Day Divided Into Two Equal Doses) During 12 Weeks of Treatment of Cataplexy in Adult… |
| Lead sponsor | UCB Pharma SA, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Narcolepsy With Cataplexy |
| Intervention type | Drug |
| Interventions | Sodium Oxybate (Xyrem) |
| Enrollment | 25 |
| Start date | Apr 10, 2006 |
| Primary completion | Jan 22, 2008 |
| Completion | Jan 22, 2008 |
| First posted | Jun 29, 2006 |
| Last update posted | Apr 8, 2022 |
| Countries | Belgium |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: